VB-119

N/A

Report date: 2025/06/09 16:50:48

Base Information

Drug NameVB-119
Drug Alias NameVB-119
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-CD19
TargetsB-lymphocyte antigen CD19
Therapy Area/IndicationsGlomerulonephritis, Membranous
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesValenzaBio Inc
China Registration ClassN/A

Develop Information

Active CompaniesValenzaBio Inc
Inactive CompaniesN/A
Active IndicationsGlomerulonephritis, Membranous
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A